According to Evofem Biosciences 's latest financial reports the company's current revenue (TTM) is $18.21 M. In 2022 the company made a revenue of $16.83 M an increase over the years 2021 revenue that were of $8.24 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $18.21 M | 8.2% |
2022 | $16.83 M | 104.23% |
2021 | $8.24 M | 1748.43% |
2020 | $0.44 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 4,639.78% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -98.76% | ๐บ๐ธ USA |